CancerGene Connect (Ommdom)
Date | Investors | Amount | Round |
---|---|---|---|
$690k | Seed | ||
N/A | $300k | Seed | |
N/A | Acquisition | ||
Total Funding | $990k |
Recent News about CancerGene Connect (Ommdom)
EditCaGene operates in the healthcare technology sector, specializing in genetic assessment platforms designed to streamline patient data collection and risk analysis. The company primarily serves healthcare providers, including hospitals and clinics, by offering tools that enhance the efficiency and accuracy of patient assessments. CaGene's core product features a Mobile Questionnaire that allows patients to share their information in real-time, providing healthcare providers with a clear view of patient progress. Additionally, the Provider Portal simplifies the organization and access to patient data, offering functionalities such as pedigree creation, viewing, and editing, as well as control over assessment models and reports. The business model is based on a subscription service, where healthcare providers pay for access to the platform and its features. Revenue is generated through these subscriptions, as well as potential add-on services and customizations. The market for CaGene's services includes healthcare institutions focused on genetic risk assessments and personalized patient care.
Keywords: genetic assessment, healthcare technology, patient data, risk analysis, mobile questionnaire, provider portal, pedigree creation, real-time data, subscription service, personalized care.